PlainAI AI explained plainly

Radiology AI vendors / FDA · 2025 · 06 · 15 · Impact · ~2 min read

AI cancer detection became routine in real hospitals

By mid-2025, over 950 AI medical devices had been cleared by the US FDA — most of them in radiology. Real hospitals were using AI as a 'second reader' on mammograms, colonoscopies, lung scans, and prostate MRIs, with peer-reviewed evidence of 20-22% better cancer detection rates. Quiet, regulated, real — the AI deployment story that doesn't trend on Twitter.

What's actually new

  • 950+ FDA-cleared AI medical devices by August 2024 — up from 221 just 18 months earlier (Stanford AI Index). Most are radiology.
  • 20-22% improvement in colorectal polyp detection when AI is used as a second reader, per peer-reviewed meta-analyses. Similar wins on breast and lung cancer.
  • Half of European radiologists were actively using AI tools by 2024. US adoption lower but rising.
  • Routine workflow integration. AI handles patient positioning, image triage, preliminary report drafting — radiologists focus on the harder reads and patient communication.
  • Multimodal models combining radiology + pathology + genomics + electronic records are emerging — the foundation for true precision oncology.

If you want more

Worth knowing~30s
  • 'AI catches more cancer' is true on average. Some studies show no improvement on advanced or obvious lesions — AI helps most on the subtle, early-stage findings.
  • FDA clearance is not the same as proof of clinical benefit. Devices clear regulatory bars; whether each one improves real outcomes is study-dependent.
  • Bias and data diversity issues remain. AI trained on majority-population images can underperform on minority groups. Real cases of this have been published.
  • Adoption is uneven. Major academic medical centres lead; community hospitals trail. The 'AI in healthcare' you read about isn't yet the AI in your local clinic.
Who should care~20s

Anyone going for a cancer screening — the AI may already be looking. Patients with cancer history. Radiologists and clinicians (the workflow has changed under your feet). Health-policy people. Insurance and reimbursement teams designing payment for AI-assisted reads.

What to do about it~20s

If you're due for a screening, ask whether the imaging centre uses AI as a second reader. Many do; many don't advertise it. The honest answer is: AI as a second reader is a quiet quality upgrade, especially in subtle cases. If you're a radiologist, the workflow is now AI-augmented by default in most modern systems — focus skill development on the parts AI demonstrably can't do (patient communication, complex differential diagnoses, hard cases AI flags as uncertain).

Honest take~45s

AI cancer detection is the AI story most often left out of the AI conversation, because it's boring. No flashy demos, no Twitter dunks — just FDA-cleared devices quietly improving cancer detection rates by 20% in 50,000+ hospitals globally. The Stanford AI Index's 950 number is the underrated AI headline of 2025. Most of AI's real impact looks like this: regulated, evidence-based, slow, slightly dull, and actually saving lives.

Other recent impact updates

Sources

Last verified · 2026 · 05 · 05 · Found a fact wrong? corrections@aguidetocloud.com